Myriad Genetics (MYGN)
Offers hereditary cancer, tumor profiling, prenatal, and GeneSight pharmacogenomic tests.
$4.17
vs last close+0.14 (+3.61%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 94.84% | 90.71M shares | |
|---|---|---|---|
| 200 holders · as of Jun 30, 2026 | |||
| Insiders | 6.28% | 6.00M shares | |
| 21 holders · as of Sep 22, 2026 | |||
| Strategic holders | 20.94% | 20.03M shares | |
| 3 holders · as of Sep 4, 2026 | |||
| Adds to | 122.06% | ||
95.65M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 122.06%; nothing is left for Other.
13F, as of Jun 30, 2026
200 holders · 90.71M shares · 44 new positions · 117 increased · 60 reduced · 51 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 10.89M | 11.39% | +2.00M | Aug 7, 2026 |
| Millennium Management LLC | 6.62M | 6.92% | −48.4K | Aug 14, 2026 |
| Vestal Point Capital, LP | 5.74M | 6.00% | +4.09M | Aug 14, 2026 |
| State Street Corp | 4.99M | 5.21% | +561.0K | Aug 7, 2026 |
| D. E. Shaw & Co., Inc. | 4.58M | 4.79% | +82.4K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 4.08M | 4.27% | +156.9K | Aug 13, 2026 |
| Acadian Asset Management LLC | 3.13M | 3.27% | +818.4K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 3.08M | 3.22% | +497.4K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 10.40% | 9.90M | 13G | Sep 4, 2026 |
| BlackRock, Inc. | 8.50% | 7.98M | 13G | Apr 7, 2026 |
| Vestal Point Capital, LP | 6.10% | 5.74M | 13G | Aug 14, 2026 |
| Integrated Core Strategies (US) LLC | 5.60% | 5.18M | 13G | Feb 11, 2026 |
| State Street Corporation | 5.30% | 4.99M | 13G | Aug 7, 2026 |
| Glenview Capital Management, LLC | 5.30% | 4.94M | 13G | Jan 13, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 8, 2026 | Rashmi Kumardirector | Sale | 15,000 | $4.46 | 171,889 |
| May 14, 2026 | Paul Bisarodirector | Purchase | 7,500 | $3.69 | 97,441 |
| Mar 9, 2026 | Samraat S. Rahadirector, officer: President and CEO | Purchase | 40,000 | $5.00 | 493,104 |
| Feb 25, 2026 | S. Louise Phanstieldirector | Purchase | 6,100 | $4.74 | 183,544 |
| Feb 26, 2026 | S. Louise Phanstieldirector | Purchase | 50,407 | $4.80 | 233,951 |
| Feb 27, 2026 | S. Louise Phanstieldirector | Purchase | 48,000 | $4.66 | 281,951 |
House and Senate disclosures
Not reported.